MONHEIM AM RHEIN, Germany & SAN JOSE, Calif.--(BUSINESS WIRE)--Resolve Biosciences today announced the commercial launch of its groundbreaking Molecular Cartography™ service offering to provide ...
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers and remains an aggressive disease with median survival of approximately 12 months for patients with extensive-stage disease Precede ...
Comprehensive epigenomic platform enables systematic and quantitative prediction of tumor gene expression from cell-free DNA Genes include key targets for next generation precision medicines, such as ...
You know, sometimes science feels like it’s moving at lightning speed, and companies like Resolve Biosciences are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results